SCHEMBL5588060

SCHEMBL5588060

Oc1c(O)c(Cl)c2c(c1Cl)Oc1cc(Cl)c(Cl)c(Cl)c1O2

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 12/20 0.64
HPGD P15428 6/20 0.41
HSD17B10 Q99714 6/20 0.41
TSHR P16473 5/20 0.41
MAPK1 P28482 2/20 0.41
CASP1 P29466 1/20 0.39
CYP3A4 P08684 4/20 0.37
HSP90AA1 P07900 2/20 0.37
AKR1B1 P15121 1/20 0.36
FLT1 P17948 1/20 0.36
ALDH1A1 P00352 1/20 0.35
CRHBP P24387 1/20 0.34
CRHR2 Q13324 1/20 0.34
MEN1 O00255 1/20 0.32
NPC1 O15118 1/20 0.32
USP2 O75604 1/20 0.32
EGFR P00533 1/20 0.32
LMNA P02545 1/20 0.32
ESR1 P03372 1/20 0.32
ERBB2 P04626 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5589159 0.90 AHR (0.53) AHRHPGDHSD17B10TSHRMAPK1
SCHEMBL29353335 0.87 AHR (0.75) AHRHPGDHSD17B10TSHRMAPK1
SCHEMBL2879834 0.87 AHR (0.75) AHRHPGDHSD17B10TSHRMAPK1
SCHEMBL29353218 0.85 AHR (0.86) AHRHPGDHSD17B10TSHRMAPK1
SCHEMBL30118871 0.85 AHR (0.86) AHRHPGDHSD17B10TSHRMAPK1
SCHEMBL5967950 0.85 AHR (0.86) AHRHPGDHSD17B10TSHRMAPK1
SCHEMBL9579657 0.85 AHR (0.86) AHRHPGDHSD17B10TSHRMAPK1
SCHEMBL5589643 0.83 AHR (0.58) AHRHPGDHSD17B10TSHRMAPK1
SCHEMBL2464142 0.83 AHR (0.82) AHRHPGDHSD17B10TSHRCYP3A4
SCHEMBL30118867 0.83 AHR (0.82) AHRHPGDHSD17B10TSHRCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 AHR 1434/4885HPGD 2689/4885HSD17B10 1640/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.